Risk factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis

被引：34

作者：

Gonzalez, Michel ^{[1
]}

Gervaz, Pascal ^{[2
]}

机构：

[1] CHU Vaudois, Div Thorac Surg, CH-1011 Lausanne, Switzerland

[2] Clin Colline, Coloproctol Unit, Geneva, Switzerland

来源：

FUTURE ONCOLOGY | 2015年 / 11卷 / 02期

关键词：

colorectal cancer; lung metastases; meta-analysis; metastasectomy; systematic review; OLIGOMETASTASES POOLED ANALYSIS; PULMONARY METASTASECTOMY; RESECTION; IRINOTECAN;

D O I：

10.2217/fon.14.259

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Despite the lack of randomized trials, lung metastasectomy is currently proposed for colorectal cancer patients under certain conditions. Many retrospective studies have reported different prognostic factors of poorer survival, but eligibility for pulmonary metastasectomy remains determined by the complete resection of all pulmonary metastases. The aim of this review is to clarify which pre-operative risk factors reported in systematic reviews or meta-analysis are determinant for survival in colorectal metastatic patients. Different criteria have been now identified to select which patient will really benefit from lung metastasectomy.

引用

页码：31 / 33

页数：3

共 15 条

[1]

[Anonymous], 2020, CA Cancer J Clin, DOI DOI 10.3322/CAAC.21590

[2] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].

Cunningham, D ;

Humblet, Y ;

Siena, S ;

Khayat, D ;

Bleiberg, H ;

Santoro, A ;

Bets, D ;

Mueser, M ;

Harstrick, A ;

Verslype, C ;

Chau, I ;

Van Cutsem, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345

[3] A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200 [J].

Giantonio, B. J. ;

Levy, D. E. ;

O'Dwyer, P. J. ;

Meropol, N. J. ;

Catalano, P. J. ;

Benson, A. B., III .

ANNALS OF ONCOLOGY, 2006, 17 (09) :1399-1403

[4] Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis [J].

Gonzalez, Michel ;

Poncet, Antoine ;

Combescure, Christophe ;

Robert, John ;

Ris, Hans Beat ;

Gervaz, Pascal .

ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (02) :572-579

[5]

Gonzalez M, 2012, EXPERT REV ANTICANC, V12, P495, DOI [10.1586/era.12.21, 10.1586/ERA.12.21]

[6] Is Lymph Node Dissection Required in Pulmonary Metastasectomy for Colorectal Adenocarcinoma? [J].

Hamaji, Masatsugu ;

Cassivi, Stephen D. ;

Shen, K. Robert ;

Allen, Mark S. ;

Nichols, Francis C. ;

Deschamps, Claude ;

Wigle, Dennis A. .

ANNALS OF THORACIC SURGERY, 2012, 94 (06) :1796-1801

[7] Nodal involvement at the time of pulmonary metastasectomy: Experiences in 245 patients [J].

Pfannschmidt, J ;

Mode, J ;

Muley, T ;

Dienemann, H ;

Hoffmann, H .

ANNALS OF THORACIC SURGERY, 2006, 81 (02) :448-454

[8] Surgical resection of pulmonary metastases from colorectal cancer: A systematic review of published series [J].

Pfannschmidt, Joachim ;

Dienemann, Hendrik ;

Hoffmann, Hans .

ANNALS OF THORACIC SURGERY, 2007, 84 (01) :324-338

[9] Reported Outcome Factors for Pulmonary Resection in Metastatic Colorectal Cancer [J].

Pfannschmidt, Joachim ;

Hoffmann, Hans ;

Dienemann, Hendrick .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) :S172-S178

[10] Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer† [J].

Renaud, Stephane ;

Alifano, Marco ;

Falcoz, Pierre-Emmanuel ;

Magdeleinat, Pierre ;

Santelmo, Nicola ;

Pages, Olivier ;

Massard, Gilbert ;

Regnard, Jean-Francois .

INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2014, 18 (04) :482-487

← 1 2 →